EMA/PE/0000181518 - paediatric investigation plan

Lerodalcibep

Key facts

• Active substance:
  Lerodalcibep
• Therapeutic area:
  Metabolism and nutrition disorders
• Decision number:
  EMA/PE/0000181518
• PIP number:
  EMA/PE/0000181518
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of hypercholesterolaemia
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  06/12/2024
• Compliance check done:
  No

Decision

EMA/PE/0000181518: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for lerodalcibep

Adopted Reference Number: EMADOC-1700519818-1766926